Safety and Efficacy of the Addition of Nemtabrutinib to Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
NCT07194980 · NOT YET RECRUITING · Phase 2
We track 3 ClinicalTrials.gov studies led by Fred Hutchinson Cancer Center. The portfolio skews toward N/A (2 trials).
3 clinical trials sponsored by Fred Hutchinson Cancer Center.
| Phase | Trials | Distribution |
|---|---|---|
| N/A | 2 | 67% |
| Phase 2 | 1 | 33% |
Fred Hutchinson Cancer Center currently sponsors 3 clinical trials tracked on ReadTheTrial. These span N/A, Phase 2.
Fred Hutchinson Cancer Center conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Fred Hutchinson Cancer Center currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.